Role of microRNA machinery in kidney fibrosis

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 8, 2014, Pages 543-550

  Wang, Bo ^a   Ricardo, Sharon ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Kidney fibrosis; MicroRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 150; MICRORNA 192; MICRORNA 200; MICRORNA 21; MICRORNA 29; MICRORNA 324; MICRORNA 433; MICRORNA LET7; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CELL COMMUNICATION; CELL TRANSFER; DOWN REGULATION; EXOSOME; GENE EXPRESSION REGULATION; HUMAN; KIDNEY FIBROSIS; NONHUMAN; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; FIBROSIS; GENETICS; KIDNEY DISEASE; METABOLISM; PATHOLOGY;

ANIMALS; FIBROSIS; HUMANS; KIDNEY DISEASES; MICRORNAS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84906242158     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12249     Document Type: Article

References (78)

1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-54.
2. Reinhart BJ, Slack FJ, Basson M et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403: 901-6.
3. Li M, Marin-Muller C, Bharadwaj U, Chow KH, Yao Q, Chen C. MicroRNAs. Control and loss of control in human physiology and disease. World J. Surg. 2009; 33: 667-84.
4. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: Stepwise processing and subcellular localization. EMBO J. 2002; 21: 4663-70.
5. Lee Y, Kim M, Han J et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004; 23: 4051-60.
6. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-33.
7. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell 2011; 146: 353-8.
8. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010; 465: 1033-8.
9. Franco-Zorrilla JM, Valli A, Todesco M et al. Target mimicry provides a new mechanism for regulation of microRNA activity. Nat. Genet. 2007; 39: 1033-7.
10. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges. Competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 2007; 4: 721-6.
11. Bao X, Zhu X, Liao B et al. MicroRNAs somatic cell reprogramming. Curr. Opin. Cell Biol. 2013; 25: 208-14.
12. Goljanek-Whysall K, Sweetman D, Munsterberg AE. MicroRNAs in skeletal muscle differentiation and disease. Clin. Sci. 2012; 123: 611-25.
13. Ji F, Lv X, Jiao J. The role of microRNAs in neural stem cells and neurogenesis. J. Genet. Genomics 2013; 40: 61-6.
14. Cullen BR. MicroRNAs as mediators of viral evasion of the immune system. Nat. Immunol. 2013; 14: 205-10.
15. Mineno J, Okamoto S, Ando T et al. The expression profile of microRNAs in mouse embryos. Nucleic Acids Res. 2006; 34: 1765-71.
16. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002; 12: 735-9.
17. Wang B, Jha JC, Hagiwara S et al. Transforming growth factor-beta1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b. Kidney Int. 2014; 85: 352-61.
18. Brennan EP, Nolan KA, Borgeson E et al. Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFbetaR1. J. Am. Soc. Nephrol. 2013; 24: 627-37.
19. Zhao C, Sun G, Li S et al. MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling. Proc. Natl Acad. Sci. USA 2010; 107: 1876-81.
20. Wang B, Herman-Edelstein M, Koh P et al. E-Cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 2010; 59: 1794-802.
21. Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008; 283: 910-4.
22. Oba S, Kumano S, Suzuki E et al. miR-200b precursor can ameliorate renal tubulointerstitial fibrosis. PLoS One 2010; 5: e13614.
23. Wang B, Koh P, Winbanks C et al. miR-200a prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes 2011; 60: 280-7.
24. Muller GA, Zeisberg M, Strutz F. The importance of tubulointerstitial damage in progressive renal disease. Nephrol. Dial. Transplant. 2000; 15(Suppl. 6): 76-7.
25. Meng XM, Chung AC, Lan HY. Role of the TGF-beta/BMP-7/Smad pathways in renal diseases. Clin. Sci. 2013; 124: 243-54.
26. Ho J, Kreidberg JA. MicroRNAs in renal development. Pediatr. Nephrol. 2013; 28: 219-25.
27. Ma L, Qu L. The function of microRNAs in renal development and pathophysiology. J. Genet. Genomics 2013; 40: 143-52.
28. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003; 112: 1776-84.
29. Rastaldi MP. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. J. Nephrol. 2006; 19: 407-12.
30. Khella HW, Bakhet M, Lichner Z, Romaschin AD, Jewett MA, Yousef GM. MicroRNAs in kidney disease: An emerging understanding. Am. J. Kidney Dis. 2013; 61: 798-808.
31. Kato M, Zhang J, Wang M et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl Acad. Sci. USA 2007; 104: 3432-7.
32. Chung AC, Huang XR, Meng X, Lan HY. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J. Am. Soc. Nephrol. 2010; 21: 1317-25.
33. Chung AC, Dong Y, Yang W, Zhong X, Li R, Lan HY. Smad7 suppresses renal fibrosis via altering expression of TGF-beta/Smad3-regulated microRNAs. Mol. Ther. 2013; 21: 388-98.
34. Putta S, Lanting L, Sun G, Lawson G, Kato M, Natarajan R. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J. Am. Soc. Nephrol. 2012; 23: 458-69.
35. Deshpande SD, Putta S, Wang M et al. Transforming growth factor-beta-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes 2013; 62: 3151-62.
36. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J. Am. Soc. Nephrol. 2010; 21: 438-47.
37. van Rooij E, Sutherland LB, Thatcher JE et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl Acad. Sci. USA 2008; 105: 027-32.
38. Kogure T, Costinean S, Yan I, Braconi C, Croce C, Patel T. Hepatic miR-29ab1 expression modulates chronic hepatic injury. J. Cell Mol. Med. 2012; 16: 2647-54.
39. Roderburg C, Urban GW, Bettermann K et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011; 53: 209-18.
40. Cushing L, Kuang PP, Qian J et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2011; 45: 287-94.
41. Wang B, Komers R, Carew R et al. Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. J. Am. Soc. Nephrol. 2012; 23: 252-65.
42. Qin W, Chung AC, Huang XR et al. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J. Am. Soc. Nephrol. 2011; 22: 1462-74.
43. Fang Y, Yu X, Liu Y et al. mir-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-alpha activation. Am. J. Physiol. Renal Physiol. 2013; 304: F1274-82.
44. Long J, Wang Y, Wang W, Chang BH, Danesh FR. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J. Biol. Chem. 2011; 286: 837-48.
45. Johnson CD, Esquela-Kerscher A, Stefani G et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 2007; 67: 7713-22.
46. Pandit KV, Corcoran D, Yousef H et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2010; 182: 220-9.
47. Pandit KV, Milosevic J, Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl. Res. 2011; 157: 191-9.
48. Roy S, Khanna S, Hussain SR et al. MicroRNA expression in response to murine myocardial infarction: MiR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 2009; 82: 21-9.
49. Thum T, Gross C, Fiedler J et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980-4.
50. Dong S, Cheng Y, Yang J et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J. Biol. Chem. 2009; 284: 514-25.
51. Liu G, Friggeri A, Yang Y et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 2010; 207: 1589-97.
52. Zarjou A, Yang S, Abraham E, Agarwal A, Liu G. Identification of a microRNA signature in renal fibrosis: Role of miR-21. Am. J. Physiol. Renal Physiol. 2011; 301: F793-801.
53. Zhong X, Chung AC, Chen HY et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 2013; 56: 663-74.
54. Glowacki F, Savary G, Gnemmi V et al. Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS One 2013; 8: e58014.
55. Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC. Urinary miR-21, miR-29, and miR-93: Novel biomarkers of fibrosis. Am. J. Nephrol. 2012; 36: 412-8.
56. Gregory PA, Bert AG, Paterson EL et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008; 10: 593-601.
57. Xiong M, Jiang L, Zhou Y et al. The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am. J. Physiol. Renal Physiol. 2012; 302: F369-79.
58. Yang Z, Tsuchiya H, Zhang Y, Hartnett ME, Wang L. MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein. J. Biol. Chem. 2013; 288: 28 893-9.
59. Gotanda K, Hirota T, Matsumoto N, Ieiri I. MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells. BMC Cancer 2013; 13: 369.
60. Li R, Chung AC, Dong Y, Yang W, Zhong X, Lan HY. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-beta/Smad3-Azin1 pathway. Kidney Int. 2013; 84: 1129-44.
61. Macconi D, Tomasoni S, Romagnani P et al. MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition. J. Am. Soc. Nephrol. 2012; 23: 1496-505.
62. He Y, Jiang X, Chen J. The role of miR-150 in normal and malignant hematopoiesis. Oncogene 2013.
63. Zhang N, Wei X, Xu L. miR-150 promotes the proliferation of lung cancer cells by targeting P53. FEBS Lett. 2013; 587: 2346-51.
64. Zhou H, Hasni SA, Perez P et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J. Am. Soc. Nephrol. 2013; 24: 1073-87.
65. Anderson P, Kedersha N. RNA granules: Post-transcriptional and epigenetic modulators of gene expression. Nat. Rev. Mol. Cell Biol. 2009; 10: 430-6.
66. Siomi H, Siomi MC. RISC hitches onto endosome trafficking. Nat. Cell Biol. 2009; 11: 1049-51.
67. Pegtel DM, van de Garde MD, Middeldorp JM. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim. Biophys. Acta 2011; 1809: 715-21.
68. Palma J, Yaddanapudi SC, Pigati L et al. MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res. 2012; 40: 9125-38.
69. Stoorvogel W. Functional transfer of microRNA by exosomes. Blood 2012; 119: 646-8.
70. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2011; 2: 282.
71. Bellingham SA, Coleman BM, Hill AF. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 2012; 40: 937-49.
72. Roccaro AM, Sacco A, Maiso P et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J. Clin. Invest. 2013; 123: 1542-55.
73. Xin H, Li Y, Liu Z et al. Mir-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 2013; 31: 2737-46.
74. Gatti S, Bruno S, Deregibus MC et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant. 2011; 26: 1474-83.
75. Peng Y, Yu S, Li H, Xiang H, Peng J, Jiang S. MicroRNAs: Emerging roles in adipogenesis and obesity. Cell Signal 2014. pii: S0898-6568(14)00176-64. doi:10.1016/j.cellsig.2014.05.006. [Epub ahead of print].
76. Schena FP, Serino G, Sallustio F. MicroRNAs in kidney diseases. New promising biomarkers for diagnosis and monitoring. Nephrol. Dial. Transplant. 2014; 29: 755-63.
77. Lv LL, Cao YH, Ni HF et al. microRNA-29c in urinary exosome/microvesicle as biomarker of renal fibrosis. Am. J. Physiol. Renal Physiol. 2013; 305: F1220-7.
78. Djuranovic S, Nahvi A, Green R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 2012; 336: 237-40.